TIL Instil Bio Inc

Price (delayed)

$8.12

Market cap

$55.07M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$7.04

Enterprise value

$134.92M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 16

Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing an innovative cell therapy pipeline of autologous TIL therapies for the treatment of patients with cancer.

Highlights
TIL's EPS is up by 41% year-on-year and by 34% since the previous quarter
TIL's net income is up by 39% YoY and by 34% QoQ
The company's equity fell by 24% YoY and by 2.8% QoQ

Key stats

What are the main financial stats of TIL

TIL stock price

How has the Instil Bio stock price performed over time
Intraday
-1.34%
1 week
0.25%
1 month
3.57%
1 year
-76.4%
YTD
-26.18%
QTD
-1.46%

Financial performance

How have Instil Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$53.41M
Net income
-$47.38M
Gross margin
N/A
Net margin
N/A
TIL's net income is up by 39% YoY and by 34% QoQ
The operating income has grown by 33% YoY and by 32% from the previous quarter

Price vs fundamentals

How does TIL's price correlate with its fundamentals

Growth

What is Instil Bio's growth rate over time

Valuation

What is Instil Bio stock price valuation
P/E
N/A
P/B
0.5
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
TIL's EPS is up by 41% year-on-year and by 34% since the previous quarter
TIL's price to book (P/B) is 62% lower than its 5-year quarterly average of 1.3 and 38% lower than its last 4 quarters average of 0.8
The company's equity fell by 24% YoY and by 2.8% QoQ

Efficiency

How efficient is Instil Bio business performance
TIL's ROIC is up by 36% since the previous quarter and by 31% year-on-year
Instil Bio's return on assets has increased by 31% QoQ and by 23% YoY
The return on equity rose by 29% since the previous quarter and by 13% year-on-year

Dividends

What is TIL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TIL.

Financial health

How did Instil Bio financials performed over time
TIL's total assets is 123% greater than its total liabilities
Instil Bio's current ratio has increased by 31% YoY
TIL's total assets is down by 16% year-on-year
Instil Bio's debt is 23% less than its equity
The debt to equity has grown by 33% YoY and by 4.1% from the previous quarter
The company's equity fell by 24% YoY and by 2.8% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.